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Abstract
Background: An estimated 30% of women worldwide experience intimate partner violence (IPV) during their lifetime.
Exposure to IPV is associated with poor health outcomes and the prevalence of violence may be higher amongst
women seeking healthcare. Existing evidence from the Arab region is limited. We conducted a systematic review and
meta-analysis of prevalence and health outcomes of domestic violence (IPV or violence from a family member) in
clinical populations in Arab countries.
Methods: Using terms related to domestic violence, Arab countries, and date limit > year 2000, we searched seven
databases: Medline, EMBASE, PsycINFO, CINAHL, Web of Science: core collection, IBSS, Westlaw, IMEMR. We included
observational studies reporting estimates of prevalence or health outcomes of domestic violence amongst women
aged > 15 years, recruited while accessing healthcare in Arab countries. Studies that collected data on/after 1st January
2000 and were published in English, Arabic or French were included. Title/abstract screening, full text screening, quality
assessment and data extraction were carried out. Extracted data were summarised and meta-analysis was performed
where appropriate.
Results: 6341 papers were screened and 41 papers (29 studies) met inclusion criteria. Total 19,101 participants from 10
countries were represented in the data. Meta-analysis produced pooled prevalence estimates of lifetime exposure to
any type of IPV of 73·3% (95% CI 64·1–81·6), physical IPV 35·6% (95% CI 24·4–47·5), sexual IPV 22% (95% CI 13·3–32) and
emotional/psychological IPV 49·8% (95% CI 37·3–62·3). Domestic violence (IPV or family violence) exposure was
associated with increased odds of adverse health outcomes: depression OR 3·3 (95% CI 1·7–6·4), sleep problems OR 3·2
(95% CI 1·5–6·8), abortion OR 3·5 (95% CI 1·2–10·2), pain OR 2·6 (95% CI 1·6–4·1) and hypertension OR 1·6 (95%
CI 1·2–2·0).
Conclusions: Domestic violence is common amongst women seeking healthcare in Arab countries. Exposure
to domestic violence is associated with several poor health outcomes. Further research into domestic violence
in the Arab world is required.
Trial registration: Systematic review protocol was registered on PROSPERO: CRD42017071415.
Keywords: Domestic violence, Intimate partner violence, Violence against women, Spouse abuse, Arab, Arabic,
Middle East, Health, Healthcare
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Background
Domestic violence is a worldwide epidemic with an esti-
mated 30% of women experiencing physical and/or
sexual violence from an intimate partner during their
lifetime [1]. Domestic violence (DV) includes violence
perpetrated by a family member or intimate partner to-
wards another adult. Much of the current international
evidence focuses on intimate partner violence (IPV),
which is a subset of domestic violence. Domestic vio-
lence may be a single incident or pattern of incidents
which can take multiple forms including physical, sexual,
psychological, emotional, financial and control violence
[2]. A severe violation of human rights, domestic vio-
lence has societal and economic costs and is increasingly
recognised as a clinical and public health issue.
There is a lack of robust prevalence data on domestic
violence from the Arab region. A 2008 systematic review
of IPV in the Middle East and North Africa highlighted
‘the very limited knowledge base on the topic’ in the
region (p67) [3]. During the period 1992–2002 just 12
prevalence studies, from community or clinical settings,
were identified. Estimated prevalence of lifetime expo-
sure to IPV in these studies ranged from 8·1% to 64·6%
[3]. The WHO estimated that 37% of women in the
Eastern Mediterranean Region (EMR) have ever expe-
rienced physical or sexual IPV [4]. This estimate was
generated from just 18 available studies compared to 114
studies used to produce the high-income countries esti-
mate. A few countries have collected community-level
prevalence data as part of large demographic health
surveys; for example 30.3% of ever-married Egyptian
women have experienced spousal violence, 18·6% within
the last year [5]. Smaller cross-sectional studies have
been conducted in community or clinical settings in
some countries [6–9].
Intimate partner violence has well documented mental
health, reproductive health and chronic physical health
consequences [4, 10]. Two previous reviews from this
region summarised the health outcomes of IPV as
reported by individual clinical or community-based
studies; meta-analysis was not performed [3, 11]. Evidence
suggests that the prevalence of IPV may be higher
amongst clinical populations, [12] but there is a lack of
synthesised data internationally. We found no other stud-
ies that produced pooled prevalence estimates for clinical
populations in the Arab region.
Domestic violence must be understood in its sociocul-
tural context [13]. Traditional Arab society values women
as wives and mothers within a patriarchal family structure,
and family cohesiveness might be prioritised over indivi-
dual rights and freedoms [14]. Despite progress in female
education, with gender parity achieved in school-age
education and women in some countries surpassing men
in tertiary education, this has not necessarily translated
into female economic empowerment or shifting domestic
power dynamics [14–16]. Women’s subordinate status is
reinforced by legal and political systems. All countries in
the Arab region, except Sudan and Somalia, have now
ratified CEDAW (Convention on the Elimination of all
forms of Discrimination Against Women), but national
responses to domestic violence have been fragmented
[16, 17]. Some countries have criminalised domestic
violence, but elsewhere it remains legal. In most Arab
countries marital rape is not a crime. Even where penal
legislation exists, survivors of domestic violence face
barriers to accessing justice. Personal status law also dis-
criminates against women with unequal access to divorce,
child custody and property rights [16]. Multiple factors
including family expectations, economic dependence and
weak legal systems might combine to prevent women
from seeking help.
With no clear consensus on which countries form the
Middle East region, we chose to focus on Arab countries.
These countries share sociocultural norms, making it suit-
able to compare and combine DV studies. Much existing
international and regional prevalence data comes from
community studies which provide best estimates of
average prevalence. Given the health impacts of DV,
women accessing healthcare may be more likely to have
experienced DV. As we are particularly interested in
DV as healthcare problem, it is useful for clinicians and
health policy makers to have data on the prevalence
and health impacts of DV within the population of women
accessing healthcare. We therefore focused our review on
clinical populations only. Our review aims to answer these
research questions: 1. What is the prevalence of DV
in clinical populations in Arab countries? 2. What are
the health outcomes of DV in clinical populations in
Arab countries?
Method
Search strategy and selection criteria
We included studies reporting prevalence or health out-
comes of DV against women aged > 15 years. Population
included residents of Arab countries (Bahrain, Egypt, Iraq,
Jordan, Kuwait, Lebanon, Libya, Morocco, Occupied
Palestinian Territory and Arab residents within Israel,
Oman, Qatar, Saudi Arabia, Somalia, Sudan, Syrian
Arab Republic, Tunisia, United Arab Emirates, Yemen)
recruited whilst accessing healthcare. Included: obser-
vational studies, data collected on/after 1st January
2000, published in English, French or Arabic. Excluded:
study population primarily migrants from non-Arab coun-
try, experimental, interventional or qualitative studies and
abstracts/conference proceedings. Studies reporting health
outcomes were included only if outcomes were separated
or compared by violence exposure.
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We included studies looking at all types of DV inclu-
ding physical, sexual, psychological, emotional, financial,
control, any violence or other types. As there is no gold
standard definition or measurement tool for DV preva-
lence, we accepted the definition/measurements used by
primary studies. We included violence perpetrated by
family members and/or intimate partners. Perpetration
of violence within a family might occur between adult
children and their parents (in either direction), from sib-
lings, in-laws or other adult family members. Violence
towards children is considered child abuse and is not
included within our definition of domestic violence; we in-
cluded female victims aged 15 and over, in line with the
WHO (World Health Organization) approach [4]. Subse-
quently, we use the term DV to refer to violence from a
family member and/or intimate partner and the term IPV
to refer to violence from an intimate partner only.
We searched seven databases on 6−7th April 2017: Med-
line, EMBASE, PsycINFO, CINAHL, Web of Science: core
collection, IBSS, Westlaw and IMEMR. Search terms used
related to violence against women (VAW) and Arab coun-
tries (see Additional file 1 for full search strategy). Initial
searches included all forms of VAW, study settings and
EMR countries. We subsequently narrowed our focus to
studies on DV, clinical populations and Arab countries
only. Grey literature search included database searches
(OpenGrey and ProQuest) and Google searches of govern-
ment and agency reports. Backward (reference list) and
forward citation (Google Scholar) searches were con-
ducted and contact was made with authors of all included
studies.
Searches, double title/abstract screening and full text
review were conducted by CH and HE using EndNote.
Disagreements were arbitrated by GF. French articles
were also reviewed by GF.
Data analysis
All data were extracted independently by two reviewers
onto Microsoft Excel. Data extracted included study de-
sign, sampling method, response rate, sample size, inclu-
sion/exclusion criteria, DV/IPV identification tool used,
participant details, violence definition and exposure
timescale. For prevalence data we recorded the number
and percentage of participants exposed to different types
of DV including any violence, physical, sexual, psycho-
logical or emotional, control, economic, or other as de-
fined by the author. This was separated by exposure
timescale: last 12 months, lifetime or during pregnancy.
Health outcomes were as defined by the primary studies.
Health outcome data were extracted separately for DV
survivors and unexposed women.
Multiple papers from a single study were included,
but only data from the paper with the largest sample or
most complete data underwent analysis for each data point.
For non-reported, unclear or inconsistent data, we con-
tacted authors to seek clarification. For a small number
of studies where we were unable to clarify key study de-
sign characteristics, we made the following assump-
tions: perpetrator of violence was IPV, timescale of
abuse was lifetime, sampling method was convenience,
residence was 100% urban if the clinic setting was
urban. Where absolute numbers and percentages were
inconsistent or could not be deduced, we used absolute
numbers. There were small number of results that were
judged, by two authors, to be invalid or non-comparable
and were excluded from analysis. For example, a physical
violence prevalence estimate which included sexual violence
and child-maltreatment in the definition was not compa-
rable to physical violence prevalence measurements from
other studies. The measurement of mental health out-
comes in a study which excluded patients on psycho-
tropic medication was judged to be invalid. Where
results are marked ‘N/A’ in the table in Additional file 2,
this indicates that data were not considered appropriate
for inclusion.
Study-level risk of bias was assessed by two authors
(CH and JU) using the 20-point AXIS tool for
cross-sectional studies [18]. Studies were given a global
rating of poor, medium or high quality, with disagree-
ments arbitrated by GF. One approach to variable study
quality in meta-analysis is to include all studies and per-
form statistical adjustment based on quality assessment.
As the AXIS tool does not give a numerical weighting of
sources of bias, we decided that it was analytically more
robust to exclude, rather than adjust for, poor-quality
studies. All studies judged to be of poor-quality by
two authors were therefore excluded from our review
and analysis.
Prevalence studies were grouped by exposure time-
scale and violence type. Meta-analysis was performed if
there were at least five studies in a group [19]. IPV and
DV were pooled separately. For any violence type we
only meta-analysed studies if they measured all three
main violence types: physical, sexual and emotional/psy-
chological. We fitted a random-effects model because
exploratory analyses indicated substantial study hete-
rogeneity. Prior to pooling, data were transformed
using Freeman-Tukey double arcsine transformation
to stabilize the variances and meet normality assump-
tions of the outcomes [20].
Sensitivity analysis was performed by assessing the
impact of removing outlying studies on heterogeneity. We
performed univariate meta-regression if there were at least
five studies with relevant data: with continuous demo-
graphic covariates (age, literacy, employment and % urban
population), and binary covariates (high or low/middle-in-
come country, refugee or non-refugee population,
Palestinian or non-Palestinian population, community
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clinic or hospital setting, women’s or general health setting,
questionnaire or interview data on DV, validated or
non-validated DV survey tool, short [1–9 questions] or
long [10 or more questions] DV survey tool) provided
there were at least two studies in each category.
We summarised health outcomes as presented by the
primary studies. We generated pooled odds ratios for
dichotomous health outcomes (e.g. abortion), where at
least five studies provided adequate data [19]. Studies
were not separated by DV or IPV, exposure timescale or
violence type for the health outcome meta-analysis.
Violence exposure was any violence type if data were
available, otherwise the most prevalent violence type in
that study. For univariate meta-regression, binary cova-
riates were high or low/middle-income country and
health outcome diagnostic method (validated tool or
not); continuous demographic covariates used were as
listed above.
Funnel plots were not used to assess for publication
bias due to substantial study heterogeneity [21].
Analyses were performed using R function metaphor.
The systematic review protocol was registered on
PROSPERO 21/08/2017 - CRD42017071415.
The funders had no role in study design, data collec-
tion/analysis/interpretation or report writing.
Results
Searches identified 6341 papers of which 41 met inclu-
sion criteria (Fig. 1), representing 29 studies [22–62].
Additional file 2 summarises study details and main
findings from all included papers.
Data representing 19,101 participants were included in
our review. Study sample size ranged from 82 to 3271, me-
dian 394. Included studies were from ten countries. Nine-
teen studies collected prevalence data by interview; ten
used self-administered questionnaires. Seventeen studies
used or modified existing validated tools for measuring do-
mestic or intimate partner violence: 7 WHO, 3 NorAQ
(NorVold Abuse Questionnaire), 2 AAS (Abuse Assess-
ment Screen), 2 HITS (Hurt, Insult, Threaten and Scream),
1 WAST (Woman Abuse Screening Tool), 1 CTS-R (Con-
flict Tactics Scale, revised) and 1 USPSTF (U.S. Preventative
Services Task Force) family screening tool for IPV. Twelve
studies used tools which were developed independently or
based on existing literature. Further detail about measure-
ment tools is provided in Additional file 2. Most studies
Fig. 1 PRISMA inclusion flowchart
Hawcroft et al. BMC Public Health          (2019) 19:315 Page 4 of 12
focused on intimate partner violence: 19 studies re-
ported IPV only, 6 studies reported DV and 4 studies
gave separate results for both IPV and DV. Further de-
tails about the perpetrators of domestic violence are in-
cluded in Additional file 3. Nineteen studies reported
health outcome data.
Demographic details were variably reported, with data
unavailable from some studies (Table 1). Data were con-
verted to enable comparison where possible. Participant
age ranged 15–68 years. Most studies only included
married/ever-married women; four included single women
and one included engaged women.
Prevalence of DV varied between studies with wide ran-
ging estimates for all violence types. Results are sum-
marised by timescale of exposure below (Tables 2, 3 and 4).
Descriptive summary statistics refer to IPV and DV com-
bined. Meta-analysis results are presented separately for
IPV or DV.
Meta-analysis generated pooled prevalence estimates of
lifetime exposure to any IPV of 73·3% (95% CI 64·1–81·6),
physical IPV 35·6% (95% CI 24·4–47·5), sexual IPV 22%
(95% CI 13·3–32) and emotional/psychological IPV 49·8%
(95% CI 37·3–62·3). Forest plots for lifetime prevalence are
presented below in Fig. 2. Forest plots for additional
meta-analyses are available in Additional file 4.
For each meta-analysis, removal of outlying studies had
little impact on the I2 statistic, so all studies were retained.
Univariate meta-regression showed no consistent asso-
ciation between study level covariates (e.g. healthcare
setting or literacy) and prevalence. Associations were de-
tected for some analyses only: prevalence of any lifetime
violence was higher in general health than women’s health
settings (82% vs 66%, p = 0·01), prevalence of lifetime
economic violence was higher in community clinics than
hospitals (45% vs 33%, p = 0·03). Lifetime physical IPV
prevalence was higher in studies using non-validated
rather than validated questionnaires (52·7% vs 27·7%,
p = 0·02) but for lifetime economic IPV, the opposite was
found (36% vs 48%, p = 0·048). Lifetime physical DV
prevalence was higher in studies with refugee populations
(45%) than non-refugees (23%) (p = 0·041). For lifetime
psychological IPV, studies with higher literacy reported
higher prevalence of violence.
For health outcome data, violence exposure varied by
perpetrator (IPV or DV), type of violence, and timescale.
The measurement of health outcomes varied between
self-reported, clinically diagnosed or measured using a
screening/diagnostic tool. Additional file 5 summarises
the health outcome data presented by primary studies.
Most studies collected binary or categorical data and re-
ported unadjusted odds ratios (OR); some used other stat-
istical measures. Odds ratios were recalculated from
absolute figures where available. Pooled effect estimates
were produced for the five health outcomes for which
there were sufficient data: depression, sleep, abortion,
pain and hypertension (Table 5). Studies were com-
bined in meta-analysis regardless of whether the study
measured IPV or DV, length of exposure timescale or
violence type.
Health outcomes were grouped into mental health,
reproductive health and general health. Depression was
the mental health outcome with the most consistent
Table 1 Demographic details as per individual studies, with average across studies
Demographic variable Data from n = studies Minimum Maximum Mean SD
Mean age (years) 24 27·4y 36·6 y 31·4y 2·8
Currently married 23 74·3% 100% 92·8% 7·3
Literate 13 52·1% 99·6% 81·7% 13·8
Formal employment 23 0·5% 66·9% 27·2% 19
Urban residence 20 31·7% 100% 86·5% 20·7
Table 2 12-month prevalence
Violence type
(12 month)
n = studies
(n = pooled)
Minimum
prevalence %
Maximum
prevalence %
Median
prevalence %
Inter-quartile
range %
Pooled
prevalence %
95% CI I2 statistic %
Any 7 11·9 72 41·6 28·8–51 – – –
Physical 9 4 39 19·2 14·8–20·1
(6 IPV) 19·6 (11·7–28·8) 96·1
Sexual 4 2·1 26·4 11 3·3–20·3 – – –
Emotional/ psychological 8 7·5 61 37·4 15·6–50
(5 IPV) 38·8 (18·8–61) 99·1
Control 1 – – 28.4 – – – –
Economic 1 – – 5.3 – – – –
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evidence: seven studies all found a significant association
with DV. Meta-analysis of five of these studies produced
a pooled OR of 3·3 (95% CI 1·7–6·4) (Fig. 3). Seven
studies considered sleep problems with five finding sig-
nificant associations. Pooled OR for five of the seven
studies was 3·2 (95% CI 1·5–6·8) (Fig. 4). Other mental
health outcomes found to be associated with domestic
violence by some studies were suicidal thoughts, suicide
attempts, anxiety, anxiety/depression, postnatal depres-
sion, stress, memory problems, distress and anguish.
See Additional file 5 for more detail.
For reproductive health, there was a mix of significant
and non-significant results for most outcomes including
vaginal bleeding, unplanned pregnancy, premature labour,
contraceptive use, stillbirth and premature rupture of
membranes. Seven studies looked at abortion with all but
one finding a significant association. Not all papers
defined whether abortion was spontaneous or induced.
Meta-analysis for abortion produced a pooled OR of 3·5
(95% CI 1·2–10·2) (Fig. 5).
General health outcomes included clinical diagnoses
such as diabetes, symptoms such as pain and measures
of general wellbeing such as mobility. Most data were
from patient-reported measures. For most outcomes,
there was a mixture of significant and non-significant
results. Six studies looking at pain all found significant
associations; Al-Modallal found associations for some
types of violence but not others [30]. Meta-analysis pro-
duced a pooled OR of 2·6 (95% CI 1·6–4·1) (Fig. 6). Five
studies looked at hypertension with two studies finding
significant associations (for some but not all types of
violence); meta-analysis produced pooled OR of 1·6 (95%
CI 1·2–2·0) (Fig. 7).
For most covariates there was insufficient data to
perform univariate meta-regression. Of the analyses
performed, two showed significant associations. Odds
of abortion in women exposed to DV were higher in
studies with higher employment levels. Odds of pain in
women exposed to DV were higher in studies set in
high-income (OR 4·3) than low/middle-income countries
(OR 1·93).
Discussion
This is the first systematic review and meta-analysis of
the prevalence and health outcomes of domestic vio-
lence in clinical settings in the Arab region. Around one
in two women experienced psychological violence, one
in three physical violence and one in five sexual violence
from an intimate partner during their lifetime, with over
70% experiencing any form of violence. These rates are
higher than community-level estimates from local demo-
graphic and health surveys (despite broadly comparable
Table 3 Lifetime prevalence
Violence type
(Lifetime)
n = studies
(n = pooled)
Minimum
prevalence %
Maximum
prevalence %
Median
prevalence %
Inter-quartile
range %
Pooled
prevalence %
95% CI I2 statistic %
Any 13 30·6 89·8 61 39·3–77
(7 IPV) 73·3 (64·1–81·6) 97·9
Physical 17 7·7 78 31·3 26·9–44·5
(12 IPV) IPV: 35·6 (24·4–47·5) 99·1
(5 DV) DV: 31·4 (18·4–46·1) 98·7
Sexual 11 4·3 48·3 18·8 8·8–28·8
(9 IPV) 22 (13·3–32) 98·7
Emotional/ psychological 14 14·7 73·4 48·8 36·7–62·8
(11 IPV) 49·8 (37·3–62·3) 99·1
Control 3 68·8 97·2 88·4 78·6–92·8 – – –
Economic 6 12 53·3 36·9 32·7–41
(5 IPV) 40·3 (33·0–47·8) 90·9
Table 4 Prevalence during pregnancy
Violence type
(Pregnancy)
n =
studies
(n = pooled)
Minimum
prevalence %
Maximum
prevalence %
Median
prevalence %
Inter-quartile
range %
Pooled
prevalence %
95% CI I2 statistic %
Any 4 6·3 44·1 26·6 10·8–41·7 – – –
Physical 6 10·4 54 15·7 12·5–29·9 – – –
Sexual 4 1·2 15·5 7·9 4·6–11·4 – – –
Emotional/ psychological 3 23·7 32·6 28·1 25·9–30·4 – – –
Hawcroft et al. BMC Public Health          (2019) 19:315 Page 6 of 12
baseline characteristics). Around one in three women in
Iraq have experienced lifetime emotional IPV, one in
four women in Egypt experienced lifetime physical IPV
and one in ten women in Jordan experienced lifetime
sexual IPV [5, 63, 64]. This may indicate a higher pre-
valence of DV amongst women seeking healthcare.
Internationally, there is a lack of pooled DV prevalence
data from clinical settings. A UK-based systematic re-
view found lifetime IPV prevalence reported by individ-
ual studies ranging from 13% in a maternity service to
41% in primary care [12]. One meta-analysis, including
primarily USA and high-income country studies, esti-
mated lifetime exposure to any type of IPV of 38% in
family medicine and 40% in emergency medicine settings
[65]. Our study is the first to produce pooled estimates
of IPV prevalence in clinical populations in the Arab
region, or indeed any low/middle-income setting.
Understanding the prevalence of DV/IPV amongst the
population of women attending healthcare settings can
inform adaptations to clinical care and health service
provision.
We found mixed evidence of associations between DV
and a wide range of general, reproductive and mental
health outcomes. This is the first study to present pooled
effect estimates of the health outcomes of DV in the
Arab region. Exposure to DV significantly increased the
odds of the five adverse health outcomes that we
meta-analysed. These figures are higher than WHO
Fig. 2 Forest plots for lifetime prevalence meta-analyses
Table 5 Health outcome meta-analysis results
Health outcome n = studies Pooled OR 95% CI I2 statistic
Depression 5 3·3 1·7–6·4 68·1
Sleep problems 5 3·2 1·5–6·8 87·4
Abortion 6 3·5 1·2–10·2 94·1
Pain 5 2·6 1·6–4·1 74·0
Hypertension 5 1·5 1·2–2·0 27·3 Fig. 3 Depression forest plot
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estimates of associations between physical and/or sexual
IPV and incident depression OR 1·97, induced abortion
OR 2·16 and pain (last 4 weeks) aOR (adjusted odds
ratio) 1·6 [4, 66]. We found no existing pooled effect
estimates for sleep or hypertension.
Strengths of this review include a pre-defined protocol
published online, a broad search strategy and inclusion
of publications in languages other than English. Two
authors completed each review stage, thereby minimi-
sing bias. Quality assessment was conducted by two
authors using a published checklist. We used robust
statistical methods and provide justification of our
analysis decisions.
The reliability of our results is limited by the quality of
the primary studies. Most were small to medium sized
cross-sectional studies; only a minority justified their
sample size. Where this was done, and specified, studies
were more often powered to detect prevalence rather
than associations with health outcomes (which would
require a larger sample). Sampling was by convenience
in most studies which may introduce selection bias.
Some studies had non-representative populations e.g.
large proportion of military police husbands [42], high
level of female employment [40], or only refugee
participants [27, 28, 30, 34, 35, 52, 53, 55]. Twenty-nine
papers reported response rates (which were generally
high) but few assessed for non-response bias. The major-
ity of studies either gained institutional ethics approval
or at least gave some consideration to ethical issues. Best
practice, according to WHO research recommendations,
includes reducing distress to research participants and
referring for additional support if required; few studies
made explicit mention of this [67].
The lack of a gold standard definition of IPV or DV
hinders this research field. Terms for categories of vio-
lence against women may be overlapping or used inter-
changeably. Studies in this review used varied methods
for measuring violence. Face-to-face interviews versus
self-administered questionnaires may impact prevalence
and recall bias may be affected by length of recall period.
International measurement tools require translation then
revalidation. Pre-existing tools may not include be-
haviours relevant to the Arab setting e.g. ‘cursing wife’s
family’. [40] Clark and colleagues used focus groups to
inform modifications to the WHO questionnaire; identi-
fication of control violence increased from 83 to 97%
[45]. Psychological, emotional and control violence are
particularly challenging to define. Some studies included
Fig. 4 Sleep problems forest plot
Fig. 5 Abortion forest plot
Fig. 6 Pain forest plot
Fig. 7 Hypertension forest plot
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what might be considered low-level behaviours e.g.
shouting, ‘taking his own decision’, ‘being threatened with
divorce’ and produced high estimates of psychological or
control violence [40, 41, 57]. It may be the frequency
and combination of these behaviours (measured by a few
of the primary studies) which determines impact. Rates
for control violence ranged from 69 to 97%, comparable
to 83% in the Iraq Family Health Survey [63]. Control
has been increasingly recognised internationally as a
specific type of domestic violence, with some countries
now criminalising coercive control [68]; control was
included as defined and measured by a small number of
studies in our review. Sexual violence can be difficult to
measure and may be underestimated; one study removed
questions due to perceived cultural sensitivity [26].
There remain gaps in the evidence on DV in clinical
populations in Arab countries. Only ten out of the
nineteen countries searched for are represented in our
review. We retrieved no relevant Palestinian studies so
could not conduct the separate analysis pre-specified in
our protocol. Most studies focused on IPV, rather than
the broader scope of all family violence. Studies which
did look at DV (violence from any adult family member)
reported in varying detail on the perpetrators of abuse
(see Additional file 3). Husbands remained the most fre-
quent abusers, sometimes in combination with other
family members. In some studies and for some violence
types, mother-in-laws were the most common (non-hus-
band) family perpetrators [25, 47, 59], and in some
studies brothers or fathers were the most common [25,
34, 35, 51]. Other perpetrators included mother,
father-in-law, other in-laws and other wives. One study
found differences in the type of abuse perpetrated by dif-
ferent family members with husbands responsible for
the majority of sexual abuse, mother-in-laws particularly
involved in mental abuse and male family members in-
volved in physical and mental abuse [25]. The available
data were not sufficient for us to conduct further ana-
lyses of violence by type of perpetrator. Despite our
interest in DV, the lack of available data meant that our
pooled prevalence results relate mostly to IPV.
Our study has several limitations. Our estimates for
prevalence and health outcomes have wide confidence
intervals and high I2 statistics, reflecting relatively small
pooled samples and high levels of between-study va-
riance. Despite wide ranging prevalence estimates, simi-
larities in study design justified pooling. Health outcome
data varied in the definition of both violence exposure
and health outcomes. Some studies only looked at
exposure to exclusive violence categories (e.g. physical
violence only); this produces a clearer picture of the
association between the violence type and specific health
outcome, but excludes the many women who are
exposed to multiple types of violence. Some papers
reported differing associations between different violence
types and the relevant health outcome. Health outcomes
were defined and measured using a range of methods.
Most studies measured a limited range of health out-
comes, for example reproductive health or mental health
only. Combining data from these varied studies enabled
the generation of pooled effect estimates but contributed
to heterogeneity of the health outcome results.
Visual inspection of forest plots and attempts to look
for patterns between outlying results and study charac-
teristics were unproductive. We quantitatively assessed
for sources of heterogeneity using univariate meta-re-
gression. There were insufficient data to do this for all co-
variates for each analysis. Where it was performed, the
small number of included studies limits reliability. None
of the associations found were consistent across different
analyses; they may represent false positives. As we were
working with summary level data, we cannot infer that
any associations found apply at the individual level.
Despite finding an association between exposure to
violence and adverse health outcomes, causality cannot
be inferred, as most studies were cross-sectional and few
specified the temporal relationship between violence
exposure and onset of the health problem. There was
insufficient measurement of confounding variables and
few studies adjusted for confounders. The associations
demonstrated could be proxy for other causal relation-
ships e.g. socioeconomic deprivation or level of edu-
cation. Interestingly, when Al-Modallal adjusted for
confounders, the positive crude odds ratios for suicidal
thoughts and attempts became negative [27].
Conclusions
Domestic violence research has progressed in the Arab
region, but robust prevalence data are still required for
some countries. Adopting standardised definitions and
measurement tools would benefit the research field. How-
ever, definitions of violence need to retain meaning in
different sociocultural contexts and adaptation of pre-
existing tools may be necessary. Data on the frequency
and severity of violence might elucidate mechanisms of
impact. We also recommend further meta-analyses to
synthesise data on the prevalence of IPV/DV in clinical
settings in other geographical regions. To test causality
between violence and adverse health outcomes, adequately
powered longitudinal studies are needed with adjustment
for confounding factors. A standardised approach to
measuring the outcomes of domestic violence, including a
core set of health outcomes with defined diagnostic cri-
teria or tools, would enable comparison between studies
and across different settings.
Many women accessing healthcare in the Arab region
have been exposed to violence from family members or in-
timate partners. In some settings, the majority of women
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were affected. We have demonstrated that the adverse
health outcomes of DV, well documented internationally,
also affect Arab women. Our findings are of interest to
clinicians and policy makers in the Arab region. Con-
tact with a healthcare professional provides an oppor-
tunity to identify survivors of violence, offer support
and refer to specialist services [69]. The WHO has
called for a healthcare response to violence against
women but much of the current evidence comes from
high-income settings [70, 71]. The results from our re-
view provide regional evidence which could be used to
inform the development of healthcare interventions
and policy. Interventions with an evidence base from
high-income or other regional settings need local adap-
tation and evaluation, taking into account not only the
cultural context but also the healthcare system re-
sources and infrastructure and national policy and legal
framework. We recommend further research in the
Arab region to establish what a suitable healthcare re-
sponse to domestic violence might look like.
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